...
首页> 外文期刊>Journal of Surgical Oncology >Vascular endothelial growth factor staining and elevated INR in advanced epithelial ovarian carcinoma.
【24h】

Vascular endothelial growth factor staining and elevated INR in advanced epithelial ovarian carcinoma.

机译:晚期上皮性卵巢癌的血管内皮生长因子染色和INR升高。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: The purpose of this study was to determine whether vascular endothelial growth factor (VEGF) expression in tumors correlates with the incidence of an elevated prothrombin time (PT), specifically an international normalized ratio (INR) > or = 1.4, in patients undergoing primary surgical cytoreduction for ovarian cancer. METHODS: INRs were obtained on all patients perioperatively. VEGF expression was determined by immunostaining of tumor specimens using published protocols. RESULTS: One hundred patients underwent surgical cytoreduction. Sixty-seven percent of patients had postoperative INR of 1.4 or greater. INRs of greater than or equal to 1.8 were found in 5% of patients. INR elevation was independent of mean estimated blood loss (EBL) with the EBL in the patients with INRs > or = 1.4 not significantly different than the EBL in the patients with INRs < 1.4 (660 ml vs. 530 ml, P = 0.09). There was a significant correlation between elevated INR and tumor VEGF immunostaining (P < 0.005). All but one patient with an elevated INR had positive VEGF staining. CONCLUSIONS: In conclusion, development of an elevated INR (INR > or = 1.4) is common in patients undergoing primary surgical cytoreduction. Positive tumor VEGF staining is very common in patients having a postoperative coagulopathy.
机译:背景:本研究的目的是确定在接受治疗的患者中,肿瘤中血管内皮生长因子(VEGF)的表达是否与凝血酶原时间(PT)升高的发生有关,特别是国际标准化比率(INR)≥1.4。卵巢癌的主要外科手术细胞减少术。方法:所有患者均获得围手术期INR。通过使用公开的方案对肿瘤标本进行免疫染色来确定VEGF表达。结果:100例患者进行了手术细胞减少。 67%的患者术后INR为1.4或更高。在5%的患者中发现INR大于或等于1.8。 INRs≥1.4的患者的INR升高与EBL的平均估计失血量(EBL)无关,而INRs <1.4的患者的INR则无显着差异(660 ml对530 ml,P = 0.09)。 INR升高与肿瘤VEGF免疫染色之间存在显着相关性(P <0.005)。除一名INR升高的患者外,其余所有患者的VEGF染色均为阳性。结论:总的来说,在接受原发性外科细胞减灭术的患者中,INR升高(INR>或= 1.4)很常见。肿瘤VEGF阳性染色在患有术后凝血病的患者中非常普遍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号